HIV Treatment Is Revolutionizing HIV Prevention
12-1-2017Excerpt cross-posted from the futureofpersonalhealth.com
Today’s HIV medications prevent transmission when taken as prescribed, reducing the number of…
HIV Treatment
FDA Approves First Two-Drug Regimen for Certain Patients with HIV
11-27-2017Cross-posted from FDA Newsroom
Director’s Note from Richard Wolitski, Ph.D., Director, HHS Office of HIV/AIDS and Infectious Disease Policy: …
SAMHSA Awards $166 Million for HIV Prevention and Treatment
10-25-2017Cross-posted from SAMHSA Newsroom
Thursday, October 5, 2017
The Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded grants tota…
Falling Behind: More Focus Needed on Retaining People in HIV Care
10-20-2017 If you had an illness that required medical treatment for the rest of your life, how easy would it be for you to take your medication 365 days a year, r…
HHS Invites Public Comment on Draft 2018-2022 Strategic Plan
10-19-2017The Department of Health and Human Services (HHS) has released a draft Strategic Plan FY 2018-2022 and is inviting comments from stakeholders.
This doc…
Partnerships for Care Project Transforms HIV Care in 22 HRSA-Funded Health Centers
10-18-2017Last month, our colleague wrote about the successes of the three-year Partnerships for Care (P4C) demonstration project in advancing primary care capacity for H…
In Case You Missed It: Highlights from the 2017 USCA
9-21-2017The 2017 United States Conference on AIDS (USCA) was held September 7–10 in Washington, DC. The conference brought together policy makers, federal officia…
Texas Acts to Facilitate Continued Access to Daily HIV Medication for Texans Living With HIV Affected by Hurricane Harvey
8-30-2017
Hurricane Harvey and its aftermath have disrupted the lives of millions of people, including people living with HIV. The Texas HIV Medication Program (THMP), …
What Does the Community Have to Say about HIV Treatment, Viral Suppression, and Sexual Transmission?
8-2-2017On June 30, 2017, the HHS Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) hosted a community-led webinar “Community Response to the Effects of H…
Drug Interaction Concerns May Negatively Affect HIV Treatment Adherence Among Transgender Women
7-24-2017Crossposted from NIAID Newsroom
Participants in NIH-Supported Study Apprehensive about Combining HIV Medications and Hormones
Transgender …